دوره 5، شماره 4 - ( 8-1396 )
جلد 5 شماره 4 صفحات 49-41 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eizadi M, Goodarzi M T. Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients. Res Mol Med (RMM) 2017; 5 (4) :41-49
URL: http://rmm.mazums.ac.ir/article-1-257-fa.html
URL: http://rmm.mazums.ac.ir/article-1-257-fa.html
ایزدی مجتبی، گودرزی محمدتقی. Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients. Research in Molecular Medicine. 1396; 5 (4) :41-49
1- گروه فیزیولوژی ورزش، دانشگاه آزاد اسلامی واحد ساوه، ساوه، ایران ، izadimojtaba2006@yahoo.com
2- مرکز تحقیقات پزشکی سلولی دانشگاه علوم پزشکی همدان، همدان، ایران
2- مرکز تحقیقات پزشکی سلولی دانشگاه علوم پزشکی همدان، همدان، ایران
چکیده: (3293 مشاهده)
Background: Recently many studies have focused on the possible role of corticosteroids inhalation on osteoporosis in asthma patients. This study aimed to determine whether the indicatives of bone formation or resorption are different between asthma patients with healthy subjects.
Materials and Methods: To achieve this outcome, twenty one middle-aged asthma patients treated with inhaled corticosteroid and the same number healthy individuals matched for age (38 ± 6.5 years of old) participated in this study by accessible sampling. All subjects were non-trained and no smoker. Serum osteocalcin (OC), alkaline phosphatase (ALP) and cross-linked telopeptides of type I collagen (CTX) were measured to assess and compare bone formation and resorption between 2 groups. An Independent sample T-test was used to compare all variables between asthma and healthy subjects.
Results: Significant differences were not observed in body weight and other anthropometrical markers between 2 groups (p > 0.05). Serum osteocalcin have shown a borderline significant lower in asthma patients than healthy subjects (p = 0.051). ALP was significantly lower in asthma patients than healthy subjects (p = 0.021). But serum CTX levels were higher in asthma patients than in healthy subjects (p=0.014).
Conclusion: Based on these finding, it is appear that inhaled corticosteroid in asthma patients can be affect bone turnover in asthma patients, although more research is needed to further explore any potential link between corticosteroids and osteoporosis.
Materials and Methods: To achieve this outcome, twenty one middle-aged asthma patients treated with inhaled corticosteroid and the same number healthy individuals matched for age (38 ± 6.5 years of old) participated in this study by accessible sampling. All subjects were non-trained and no smoker. Serum osteocalcin (OC), alkaline phosphatase (ALP) and cross-linked telopeptides of type I collagen (CTX) were measured to assess and compare bone formation and resorption between 2 groups. An Independent sample T-test was used to compare all variables between asthma and healthy subjects.
Results: Significant differences were not observed in body weight and other anthropometrical markers between 2 groups (p > 0.05). Serum osteocalcin have shown a borderline significant lower in asthma patients than healthy subjects (p = 0.051). ALP was significantly lower in asthma patients than healthy subjects (p = 0.021). But serum CTX levels were higher in asthma patients than in healthy subjects (p=0.014).
Conclusion: Based on these finding, it is appear that inhaled corticosteroid in asthma patients can be affect bone turnover in asthma patients, although more research is needed to further explore any potential link between corticosteroids and osteoporosis.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
